Literature DB >> 3394803

Role of the Ito cell in liver parenchymal fibrosis in rats fed alcohol and a high fat-low protein diet.

S W French1, K Miyamoto, K Wong, L Jui, L Briere.   

Abstract

Eight pairs of young adult rats were pair-fed a high fat-low protein diet and ethanol or isocaloric glucose by permanent intragastric cannula for up to 6 months. Biopsies of the liver were taken monthly and the fibrosis was quantitated morphometrically using the sirius red polarization method of collagen visualization by light microscopy. Morphometric analysis of the sinusoids and scars were performed on electron micrographs made from the liver biopsies. An increase in the collagen in both the central and portal areas was found when the livers of the alcohol-fed rats were compared with controls. The predominant cell in the scars was the Ito cell. An increase in the percentage of the total Ito cell square area made up of rough endoplasmic reticulum (RER) was noted when the sinusoids of the liver of the ethanol-fed rats were compared with controls. No difference in the RER was found when the sinusoidal Ito cells were compared with the Ito cells located within the scars of the ethanol-fed rats. It was concluded that Ito cell "activation" by chronic ethanol feeding in the sinusoids of rats accurately predicts "activation" of the Ito cells within scars. The Ito cells are diffusely activated even though the scarring is localized. This implies that local factors as well as Ito cell activation are necessary for scar formation. In the case of alcoholic liver disease, scar formation may be initiated by centrilobular necrosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3394803      PMCID: PMC1880614     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

1.  Liver damage produced by feeding alcohol or sugar and its prevention by choline.

Authors:  C H BEST; W S HARTROFT
Journal:  Br Med J       Date:  1949-11-05

2.  Alcohol and sucrose in choline deficiency cirrhosis in the rat.

Authors:  A J Patek; S C Bowry; S Anurax
Journal:  Arch Pathol       Date:  1973-12

3.  The energy cost of the metabolism of drugs, including ethanol.

Authors:  R C Pirola; C S Lieber
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

4.  Relation between central canals and portal tracts in alcoholic hepatitis. A contribution to the pathogenesis of cirrhosis in alcoholics.

Authors:  M A Gerber; H Popper
Journal:  Hum Pathol       Date:  1972-06       Impact factor: 3.466

5.  Effects of ethanol ingestion and dietary fat levels on mitochondrial lipids in male and female rats.

Authors:  J A Thompson; R C Reitz
Journal:  Lipids       Date:  1978-08       Impact factor: 1.880

6.  Fat-storing cells (lipocytes) in human liver.

Authors:  S Bronfenmajer; F Schaffner; H Popper
Journal:  Arch Pathol       Date:  1966-11

7.  Sequential changes of extracellular matrix and proliferation of Ito cells with enhanced expression of desmin and actin in focal hepatic injury.

Authors:  K Ogawa; J Suzuki; H Mukai; M Mori
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

8.  Collagen production by rat liver fat-storing cells in primary culture.

Authors:  T Kawase; Y Shiratori; T Sugimoto
Journal:  Exp Cell Biol       Date:  1986

9.  Histophotometric estimation of volume density of collagen as an indication of fibrosis in rat liver.

Authors:  J James; K S Bosch; F M Zuyderhoudt; J M Houtkooper; J van Gool
Journal:  Histochemistry       Date:  1986

10.  Immunocytochemical detection of desmin in fat-storing cells (Ito cells).

Authors:  Y Yokoi; T Namihisa; H Kuroda; I Komatsu; A Miyazaki; S Watanabe; K Usui
Journal:  Hepatology       Date:  1984 Jul-Aug       Impact factor: 17.425

View more
  13 in total

1.  Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers.

Authors:  A Schmitt-Gräff; S Krüger; F Bochard; G Gabbiani; H Denk
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

2.  Proliferation of collagen fibrils and Ito cells in the liver after Japanese sake administration in undernourished rats as demonstrated by scanning electron microscopy.

Authors:  S Hattori; T Itoshima; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1992-02

3.  Role of transforming growth factor-[beta]1 in inhibiting endothelial cell proliferation in experimental alcoholic liver disease.

Authors:  A A Nanji; S R Tahan; M Golding; S Khwaja; A Rahemtulla; E N Lalani
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 4.  Aetiology and pathophysiology of chronic liver disorders.

Authors:  J Schölmerich; A Holstege
Journal:  Drugs       Date:  1990       Impact factor: 9.546

5.  Modulation of perisinusoidal cell cytoskeletal features during experimental hepatic fibrosis.

Authors:  A Schmitt-Gräff; G Chakroun; G Gabbiani
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 6.  How to prevent alcoholic liver disease.

Authors:  S W French
Journal:  Exp Mol Pathol       Date:  2015-03-07       Impact factor: 3.362

7.  Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis.

Authors:  Barbara Ulmasov; Zekuan Xu; Laura H Tetri; Tadashi Inagami; Brent A Neuschwander-Tetri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

8.  An interleukin-1 receptor antagonist decreases fibrosis induced by dimethylnitrosamine in rat liver.

Authors:  R Mancini; A Benedetti; A M Jezequel
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Liver morphology and function in visceral leishmaniasis (Kala-azar).

Authors:  I A el Hag; F A Hashim; I A el Toum; M Homeida; M el Kalifa; A M el Hassan
Journal:  J Clin Pathol       Date:  1994-06       Impact factor: 3.411

10.  Liver collagen of rats submitted to chronic intoxication with acetaldehyde.

Authors:  E Bańkowski; E Pawlicka; K Sobolewski
Journal:  Mol Cell Biochem       Date:  1993-04-07       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.